Constitutive phosphorylation of the S6 ribosomal protein via mTOR and ERK signaling in the peripheral blasts of acute leukemia patients
Authors:
- Mark D. MindenMMMark D. Minden
- David W. HedleyDHDavid W. Hedley
- 1 September 2006
- journal article
- research article
- Published by Elsevier in Experimental Hematology
- Vol. 34 (9) , 1182-1190
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Pharmacodynamic monitoring of BAY 43‐9006 (Sorafenib) in phase I clinical trials involving solid tumor and AML/MDS patients, using flow cytometry to monitor activation of the ERK pathway in peripheral blood cellsCytometry Part B: Clinical Cytometry, 2006
- Whole blood fixation and permeabilization protocol with red blood cell lysis for flow cytometry of intracellular phosphorylated epitopes in leukocyte subpopulationsCytometry Part A, 2005
- Quantitative single cell determination of ERK phosphorylation and regulation in relapsed and refractory primary acute myeloid leukemiaLeukemia, 2005
- Molecularly Targeted Therapy in Acute Myeloid LeukemiaAnnals of the New York Academy of Sciences, 2004
- Targeted cancer therapyNature, 2004
- Single Cell Profiling of Potentiated Phospho-Protein Networks in Cancer CellsCell, 2004
- Survival signalling by Akt and eIF4E in oncogenesis and cancer therapyNature, 2004
- mTOR Controls Cell Cycle Progression through Its Cell Growth Effectors S6K1 and 4E-BP1/Eukaryotic Translation Initiation Factor 4EMolecular and Cellular Biology, 2004
- Immunoreactivity of Stat5 phosphorylated on tyrosine as a cell‐based measure of Bcr/Abl kinase activityCytometry Part A, 2003
- Phosphoinositide 3-Kinase Activation Regulates Cell Division Time by Coordinated Control of Cell Mass and Cell Cycle Progression RateJournal of Biological Chemistry, 2003